Doctor profile · Federal record
Dr. Linda Diteodoro, MD
Gastroenterology Physician (CMS: Gastroenterology) · Jacksonville, FL
- NPI 1902965684
- Accepts Medicare
- MIPS 77.2 / 100 · 2023
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4800 Belfort Road, 2Nd Floor
Jacksonville, FL 32256
(904) 398-7205
fax (904) 396-4047
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- May 20, 2011
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Florida #ME98832
- Medicaid
- FL #000085400
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902965684. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,267
Distinct HCPCS
10
Medicare allowed
$156,098
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,290 | 17 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 269 | 193 | $127 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 88 | 87 | $156 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 76 | 73 | $102 | |
J7050 |
Infusion, normal saline solution, 250 cc | 69 | 32 | $1 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 68 | 43 | $80 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 60 | 60 | $174 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 59 | 43 | $51 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 41 | 41 | $167 | |
43235 |
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | 39 | $106 |
In context: peer comparison
Among 44 peers in Jacksonville Gastroenterology Physician, average services per provider: 115. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$495
Transactions
17
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Enterra Medical, INC. | 1 | $206.61 | |
| Abbvie INC. | 10 | $157.49 | |
| Gilead Sciences, INC. | 2 | $51.60 | |
| Genzyme Corporation | 2 | $50.06 | |
| Pfizer INC. | 1 | $15.71 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $13.30 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
743
Patients
204
Total drug cost
$217,778
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 360 | 109 | $7,649 |
| Omeprazole | Generic | 75 | 25 | $1,238 |
| Famotidine | Generic | 60 | 17 | $438 |
| Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,Mag Sulfates) | Brand | 38 | 37 | $3,032 |
| Creon (Lipase/Protease/Amylase) | Brand | 37 | 0 | $115,440 |
| Linzess (Linaclotide) | Brand | 29 | 0 | $15,954 |
| Ursodiol | Generic | 21 | 0 | $4,836 |
| Esomeprazole Magnesium | Generic | 20 | 0 | $443 |
| Xifaxan (Rifaximin) | Brand | 19 | 0 | $59,477 |
| Gavilyte-G (Peg3350/Sod Sulf,Bicarb,Cl/Kcl) | Brand | 16 | 16 | $241 |
Hospital affiliations
Frequently asked questions
What is Dr. Linda Diteodoro's medical specialty?
Dr. Linda Diteodoro practices Gastroenterology Physician in Jacksonville, FL.
Where does Dr. Linda Diteodoro practice?
Dr. Linda Diteodoro practices at 4800 Belfort Road, Jacksonville, FL 32256. Office phone: 9043987205.
What is Dr. Linda Diteodoro's NPI?
Dr. Linda Diteodoro's National Provider Identifier (NPI) is 1902965684, issued by NPPES.
Does Dr. Linda Diteodoro accept Medicare assignment?
Yes. Dr. Linda Diteodoro accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Linda Diteodoro commonly perform?
Top Medicare-reported procedures in 2023: Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Established patient office or other outpatient visit (HCPCS 99214); Biopsy of large bowel using a flexible endoscope (HCPCS 45380). Source: CMS Medicare Physician & Other Practitioners file.